Compare LLY & PANW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LLY | PANW |
|---|---|---|
| Founded | 1876 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer peripheral equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0T | 212.3B |
| IPO Year | 2007 | 2012 |
| Metric | LLY | PANW |
|---|---|---|
| Price | $1,122.34 | $280.14 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 19 | 39 |
| Target Price | ★ $1,218.84 | $216.28 |
| AVG Volume (30 Days) | 2.4M | ★ 8.5M |
| Earning Date | 04-30-2026 | 05-19-2026 |
| Dividend Yield | ★ 0.81% | N/A |
| EPS Growth | ★ 95.99 | N/A |
| EPS | ★ 8.26 | 0.79 |
| Revenue | ★ $65,179,000,000.00 | $2,273,100,000.00 |
| Revenue This Year | $27.15 | $24.93 |
| Revenue Next Year | $16.04 | $19.97 |
| P/E Ratio | ★ $136.88 | $359.49 |
| Revenue Growth | ★ 44.70 | 29.04 |
| 52 Week Low | $623.78 | $139.57 |
| 52 Week High | $1,182.73 | $302.95 |
| Indicator | LLY | PANW |
|---|---|---|
| Relative Strength Index (RSI) | 59.52 | 63.96 |
| Support Level | $1,032.70 | $179.81 |
| Resistance Level | $1,182.73 | $302.95 |
| Average True Range (ATR) | 37.34 | 13.79 |
| MACD | -2.58 | -2.37 |
| Stochastic Oscillator | 52.27 | 58.38 |
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Palo Alto Networks is a platform-based cybersecurity vendor with product offerings covering network security, cloud security, and security operations. The California-based firm has more than 80,000 enterprise customers across the world, including more than three-fourths of the Global 2000.